Expression of myoferlin in human and murine carcinoma tumors: Role in membrane repair, cell proliferation, and tumorigenesis

American Journal of Pathology

Volumn 182, Issue 5, 2013, Pages 1900-1909

  Leung, Cleo ^a,b   Yu, Carol ^a,b   Lin, Michelle I ^a,b   Tognon, Cristina ^b   Bernatchez, Pascal ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYOFERLIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; ANIMALS; CALCIUM-BINDING PROTEINS; CARCINOGENESIS; CARCINOMA; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE PROTEINS; MICE; MUSCLE PROTEINS;

EID: 84876529480     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.041     Document Type: Article

References (51)

1. R.G. Anderson, B.A. Kamen, K.G. Rothberg, and S.W. Lacey Potocytosis: sequestration and transport of small molecules by caveolae Science 255 1992 410 411
2. A.M. van der Bliek, and E.M. Meyerowitz Dynamin-like protein encoded by the Drosophila shibire gene associated with vesicular traffic Nature 351 1991 411 414
3. H.A. Belete, L.M. Godin, R.W. Stroetz, and R.D. Hubmayr Experimental models to study cell wounding and repair Cell Physiol Biochem 25 2010 71 80
4. Y. Argon, and S. Ward Caenorhabditis elegans fertilization-defective mutants with abnormal sperm Genetics 96 1980 413 433
5. S. Ward, Y. Argon, and G.A. Nelson Sperm morphogenesis in wild-type and fertilization-defective mutants of Caenorhabditis elegans J Cell Biol 91 1981 26 44
6. N.L. Washington, and S. Ward FER-1 regulates Ca2+ -mediated membrane fusion during C. elegans spermatogenesis J Cell Sci 119 2006 2552 2562
7. S. Britton, T. Freeman, E. Vafiadaki, S. Keers, R. Harrison, K. Bushby, and R. Bashir The third human FER-1-like protein is highly similar to dysferlin Genomics 68 2000 313 321
8. I. Roux, S. Safieddine, R. Nouvian, M. Grati, M.C. Simmler, A. Bahloul, I. Perfettini, M. Le Gall, P. Rostaing, G. Hamard, A. Triller, P. Avan, T. Moser, and C. Petit Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse Cell 127 2006 277 289
9. D.B. Davis, A.J. Delmonte, C.T. Ly, and E.M. McNally Myoferlin, a candidate gene and potential modifier of muscular dystrophy Hum Mol Genet 9 2000 217 226
10. D. Bansal, and K.P. Campbell Dysferlin and the plasma membrane repair in muscular dystrophy Trends Cell Biol 14 2004 206 213
11. D. Bansal, K. Miyake, S.S. Vogel, S. Groh, C.C. Chen, R. Williamson, P.L. McNeil, and K.P. Campbell Defective membrane repair in dysferlin-deficient muscular dystrophy Nature 423 2003 168 172
12. N.J. Lennon, A. Kho, B.J. Bacskai, S.L. Perlmutter, B.T. Hyman, and R.H. Brown Jr. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing J Biol Chem 278 2003 50466 50473
13. Y. Huang, S.H. Laval, A. van Remoortere, J. Baudier, C. Benaud, L.V. Anderson, V. Straub, A. Deelder, R.R. Frants, J.T. den Dunnen, K. Bushby, and S.M. van der Maarel AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration FASEB J 21 2007 732 742
14. B.N. Ampong, M. Imamura, T. Matsumiya, M. Yoshida, and S. Takeda Intracellular localization of dysferlin and its association with the dihydropyridine receptor Acta Myol 24 2005 134 144
15. Leung C, Utokaparch S, Sharma A, Yu C, Abraham T, Borchers C, Bernatchez P: Proteomic identification of dysferlin-interacting protein complexes in human vascular endothelium. Biochem Biophys Res Commun 415:263-269
16. F.C. Luft Dysferlin, dystrophy, and dilatative cardiomyopathy J Mol Med 85 2007 1157 1159
17. C.T. Lang, K.B. Markham, N.J. Behrendt, A.A. Suarez, P. Samuels, D.D. Vandre, J.M. Robinson, and W.E. Ackerman 4th Placental dysferlin expression is reduced in severe preeclampsia Placenta 30 2009 711 718
18. A. Karsan, J. Blonder, J. Law, E. Yaquian, D.A. Lucas, T.P. Conrads, and T. Veenstra Proteomic analysis of lipid microdomains from lipopolysaccharide- activated human endothelial cells J Proteome Res 4 2005 349 357
19. M.C. Eisenberg, Y. Kim, R. Li, W.E. Ackerman, D.A. Kniss, and A. Friedman Mechanistic modeling of the effects of myoferlin on tumor cell invasion Proc Natl Acad Sci USA 108 2011 20078 20083
20. P.N. Bernatchez, L. Acevedo, C. Fernandez-Hernando, T. Murata, C. Chalouni, J. Kim, H. Erdjument-Bromage, V. Shah, J.P. Gratton, E.M. McNally, P. Tempst, and W.C. Sessa Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function J Biol Chem 282 2007 30745 30753
21. P.N. Bernatchez, A. Sharma, P. Kodaman, and W.C. Sessa Myoferlin is critical for endocytosis in endothelial cells Am J Physiol Cell Physiol 297 2009 C484 C492
22. A. Sharma, C. Yu, C. Leung, A. Trane, M. Lau, S. Utokaparch, F. Shaheen, N. Sheibani, and P. Bernatchez A new role for the muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis Arterioscler Thromb Vasc Biol 30 2010 2196 2204
23. S. Wolff, and D. Scott Repair of radiation-induced damage to chromosomes. Independence of known DNA dark repair mechanisms Exp Cell Res 55 1969 9 16
24. R.V. Ponder, and E. Ponder Erythrophagocytosis in cancer-bearing and lymphoma-bearing mice Nature 181 1958 1537
25. H. Han, D.J. Bearss, L.W. Browne, R. Calaluce, R.B. Nagle, and D.D. Von Hoff Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray Cancer Res 62 2002 4532
26. J.P. Gratton, P. Bernatchez, and W.C. Sessa Caveolae and caveolins in the cardiovascular system Circ Res 94 2004 1408 1417
27. Z. Li, C.E. Tognon, F.J. Godinho, L. Yasaitis, H. Hock, J.I. Herschkowitz, C.L. Lannon, E. Cho, S.J. Kim, R.T. Bronson, C.M. Perou, P.H. Sorensen, and S.H. Orkin ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex Cancer Cell 12 2007 542 558
28. C. Tognon, M. Garnett, E. Kenward, R. Kay, K. Morrison, and P.H. Sorensen The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation Cancer Res 61 2001 8909 8916
29. C. Tognon, S.R. Knezevich, D. Huntsman, C.D. Roskelley, N. Melnyk, J.A. Mathers, L. Becker, F. Carneiro, N. MacPherson, D. Horsman, C. Poremba, and P.H. Sorensen Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma Cancer Cell 2 2002 367 376
30. Yu C, Sharma A, Trane A, Utokaparch S, Leung C, Bernatchez P: Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo. Vascul Pharmacol 55:26-33
31. P.N. Bernatchez, P.M. Bauer, J. Yu, J.S. Prendergast, P. He, and W.C. Sessa Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides Proc Natl Acad Sci USA 102 2005 761 766
32. C.E. Tognon, A.M. Somasiri, V.E. Evdokimova, G. Trigo, E.E. Uy, N. Melnyk, J.M. Carboni, M.M. Gottardis, C.D. Roskelley, M. Pollak, and P.H. Sorensen ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway Cancer Res 71 2011 1060 1070
33. V. Evdokimova, C. Tognon, T. Ng, P. Ruzanov, N. Melnyk, D. Fink, A. Sorokin, L.P. Ovchinnikov, E. Davicioni, T.J. Triche, and P.H. Sorensen Translational activation of Snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition Cancer Cell 15 2009 402 415
34. S. Hochmeister, R. Grundtner, J. Bauer, B. Engelhardt, R. Lyck, G. Gordon, T. Korosec, A. Kutzelnigg, J.J. Berger, M. Bradl, R.E. Bittner, and H. Lassmann Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis J Neuropathol Exp Neurol 65 2006 855 865
35. J.E. Galvin, D. Palamand, J. Strider, M. Milone, and A. Pestronk The muscle protein dysferlin accumulates in the Alzheimer brain Acta Neuropathol 112 2006 665 671
36. A. Kesari, M. Fukuda, S. Knoblach, R. Bashir, G.A. Nader, D. Rao, K. Nagaraju, and E.P. Hoffman Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset Am J Pathol 173 2008 1476 1487
37. J.A. Roche, R.M. Lovering, R. Roche, L.W. Ru, P.W. Reed, and R.J. Bloch Extensive mononuclear infiltration and myogenesis characterize the recovery of dysferlin-null skeletal muscle from contraction-induced injuries Am J Physiol Cell Physiol 298 2010 C298 C312
38. J.M. Robinson, W.E. Ackerman 4th, N.J. Behrendt, and D.D. Vandre While dysferlin and myoferlin are coexpressed in the human placenta, only dysferlin expression is responsive to trophoblast fusion in model systems Biol Reprod 81 2009 33 39
39. J.A. Roche, L.W. Ru, A.M. O'Neill, W.G. Resneck, R.M. Lovering, and R.J. Bloch Unmasking potential intracellular roles for dysferlin through improved immunolabeling methods J Histochem Cytochem 59 2011 964 975
40. C.A. Iacobuzio-Donahue, A. Maitra, M. Olsen, A.W. Lowe, N.T. van Heek, C. Rosty, K. Walter, N. Sato, A. Parker, R. Ashfaq, E. Jaffee, B. Ryu, J. Jones, J.R. Eshleman, C.J. Yeo, J.L. Cameron, S.E. Kern, R.H. Hruban, P.O. Brown, and M. Goggins Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays Am J Pathol 162 2003 1151 1162
41. J. Stec, J. Wang, K. Coombes, M. Ayers, S. Hoersch, D.L. Gold, J.S. Ross, K.R. Hess, S. Tirrell, G. Linette, G.N. Hortobagyi, W. Fraser Symmans, and L. Pusztai Comparison of the predictive accuracy of DNA array-based multigene classifiers across cDNA arrays and Affymetrix GeneChips J Mol Diagn 7 2005 357 367
42. B. Rosenberg, L. VanCamp, J.E. Trosko, and V.H. Mansour Platinum compounds: a new class of potent antitumour agents Nature 222 1969 385 386
43. D.A. Fuchs, and R.K. Johnson Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison Cancer Treat Rep 62 1978 1219 1222
44. F.A. Fornari Jr., W.D. Jarvis, S. Grant, M.S. Orr, J.K. Randolph, F.K. White, V.R. Mumaw, E.T. Lovings, R.H. Freeman, and D.A. Gewirtz Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin Cell Growth Differ 5 1994 723 733
45. F.A. Fornari, J.K. Randolph, J.C. Yalowich, M.K. Ritke, and D.A. Gewirtz Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells Mol Pharmacol 45 1994 649 656
46. N. Brock The history of the oxazaphosphorine cytostatics Cancer 78 1996 542 547
47. S.S. Chae, J.H. Paik, M.L. Allende, R.L. Proia, and T. Hla Regulation of limb development by the sphingosine 1-phosphate receptor S1p1/EDG-1 occurs via the hypoxia/VEGF axis Dev Biol 268 2004 441 447
48. S.S. Chae, J.H. Paik, H. Furneaux, and T. Hla Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference J Clin Invest 114 2004 1082 1089
49. Demonbreun AR, Fahrenbach JP, Deveaux K, Earley JU, Pytel P, McNally EM: Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Hum Mol Genet 20:779-789
50. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
51. R. Li, W.E. Ackerman 4th, C. Mihai, L.I. Volakis, S. Ghadiali, and D.A. Kniss Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and Stalls invasion PLoS One 7 2012 e39766